Literature DB >> 33430527

Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1/ESR2 in Glucose Transporter GLUT4 Regulation.

Karen Cristina Rego Gregorio1, Caroline Pancera Laurindo1, Ubiratan Fabres Machado1.   

Abstract

Impaired circulating estrogen levels have been related to impaired glycemic homeostasis and diabetes mellitus (DM), both in females and males. However, for the last twenty years, the relationship between estrogen, glycemic homeostasis and the mechanisms involved has remained unclear. The characterization of estrogen receptors 1 and 2 (ESR1 and ESR2) and of insulin-sensitive glucose transporter type 4 (GLUT4) finally offered a great opportunity to shed some light on estrogen regulation of glycemic homeostasis. In this manuscript, we review the relationship between estrogen and DM, focusing on glycemic homeostasis, estrogen, ESR1/ESR2 and GLUT4. We review glycemic homeostasis and GLUT4 expression (muscle and adipose tissues) in Esr1-/- and Esr2-/- transgenic mice. We specifically address estradiol-induced and ESR1/ESR2-mediated regulation of the solute carrier family 2 member 4 (Slc2a4) gene, examining ESR1/ESR2-mediated genomic mechanisms that regulate Slc2a4 transcription, especially those occurring in cooperation with other transcription factors. In addition, we address the estradiol-induced translocation of ESR1 and GLUT4 to the plasma membrane. Studies make it clear that ESR1-mediated effects are beneficial, whereas ESR2-mediated effects are detrimental to glycemic homeostasis. Thus, imbalance of the ESR1/ESR2 ratio may have important consequences in metabolism, highlighting that ESR2 hyperactivity assumes a diabetogenic role.

Entities:  

Keywords:  ESR1; ESR2; GLUT4; diabetes mellitus; estradiol; glycemic homeostasis; phytoestrogens

Year:  2021        PMID: 33430527     DOI: 10.3390/cells10010099

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  8 in total

Review 1.  The Interaction of Insulin and Pituitary Hormone Syndromes.

Authors:  Marie Helene Schernthaner-Reiter; Peter Wolf; Greisa Vila; Anton Luger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

Review 2.  Activation of Insulin Signaling by Botanical Products.

Authors:  Tovit Rosenzweig; Sanford R Sampson
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

3.  Investigating the Mechanisms of Pollen Typhae in the Treatment of Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking.

Authors:  Rongrong Zhou; Yuqing Zhang; Liyun Duan; Yuehong Zhang; Yingying Duan; Xiaomin Kang; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-03       Impact factor: 2.629

4.  Molecular Proof of a Clinical Concept: Expression of Estrogen Alpha-, Beta-Receptors and G Protein-Coupled Estrogen Receptor 1 (GPER) in Histologically Assessed Common Nevi, Dysplastic Nevi and Melanomas.

Authors:  Magdalena Spałkowska; Grzegorz Dyduch; Elżbieta Broniatowska; Giovanni Damiani; Anna Wojas-Pelc
Journal:  Medicina (Kaunas)       Date:  2021-11-11       Impact factor: 2.430

5.  Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women.

Authors:  Fozia Ahmed; Prasad G Kamble; Susanne Hetty; Giovanni Fanni; Milica Vranic; Assel Sarsenbayeva; Robin Kristófi; Kristina Almby; Maria K Svensson; Maria J Pereira; Jan W Eriksson
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

6.  Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study.

Authors:  Qiaoyan Lin; Yongwei Lu; Rong Lu; Yujuan Chen; Linghua Wang; Jianping Lu; Xianren Ye
Journal:  Ther Clin Risk Manag       Date:  2022-08-09       Impact factor: 2.755

Review 7.  Glucose transporters: Important regulators of endometrial cancer therapy sensitivity.

Authors:  Xing Zhang; Jia-Jing Lu; Ayitila Abudukeyoumu; Ding-Yu Hou; Jing Dong; Jiang-Nan Wu; Li-Bing Liu; Ming-Qing Li; Feng Xie
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

8.  Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy.

Authors:  Qixin Guo; Qingqing Zhu; Ting Zhang; Qiang Qu; Iokfai Cheang; Shengen Liao; Mengli Chen; Xu Zhu; Mengsha Shi; Xinli Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.